SuperworthSutro Biopharma market cap STRO
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $154.7M
- Highest close in our data
- $1.1B
- Mar 2021
Sutro Biopharma is worth $154.7M at the close on Oct 23, 2026, at $9.33 a share.
That is up 74% over the last year and down 83% over five years.
Its highest close in our data was $1.1B in Mar 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $154.7M | $93.3M | $666.7M | +58% |
| 2025 | $97.8M | $44M | $168.2M | −37% |
| 2024 | $155.8M | $155M | $410.6M | −40% |
| 2023 | $261.5M | $125.9M | $471.9M | −44% |
| 2022 | $464.4M | $181.2M | $495.1M | −33% |
| 2021 | $688.5M | $659.4M | $1.1B | −18% |
| 2020 | $838.1M | $168.2M | $885.2M | +231% |
| 2019 | $253.5M | $185M | $273.3M | +28% |
| 2018 | $198.6M | $198.6M | $285.4M | n/a |
Against its peers
Companies in Healthcare nearest Sutro Biopharma's size, closest first, today.
| Company | Market cap |
|---|---|
| STROSutro Biopharma | $154.7M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| ELMDElectromed | $220.6M |
| UTMDUtah Medical Products | $236.3M |
| KEQUKewaunee Scientific | $94.9M |
| ICCCImmucell | $93.1M |
| INFUInfuSystem | $277.6M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $202.4M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Sutro Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.